Investors

Events & Presentations

Event Details

Kymera Therapeutics First Quarter 2023 Earnings Conference Call

May 4, 2023 8:30 AM EDT

Investor Contact

Bruce Jacobs, CFA, MBA
Chief Financial Officer
investors@kymeratx.com

Christopher F. Brinzey
Westwicke, an ICR Company for Kymera Therapeutics
chris.brinzey@westwicke.com 
+ 1 339.970.2843
 

Media Contact

Todd Cooper
Sr. Vice President, Corporate Affairs
media@kymeratx.com

Sign Up for Email Alerts